Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Barsotti

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Arthritis Care & Research|December 30, 2025
MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRYEnrico De Lorenzis, Gerlando Natalello, Rossella De Angelis, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Timing of onset affects arthritis presentation pattern in antisyntethase syndromeMiguel A González-Gay, Carlomaurizio Montecucco, Albert Selva-O'Callaghan, et al.
Clinical and Experimental Rheumatology|February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodiesLorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Journal of Clinical Medicine|November 23, 2019
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time CourseLorenzo Cavagna, Ernesto Trallero-Araguás, Federica Meloni, et al.
Pageof 8